CHN Drug Study

WEST VISAYAS STATE UNIVERSITY
COLLEGE OF NURSING
La Paz, Iloilo City
DRUG STUDY
Name of Patient: ___mother hermonio______________

Bed/ Ward No.: __________________ Attending Physician:
________________________________________
Age: ________________
Impression/ Diagnosis:
_____________________________________
Name of Drug
Dosage, Route,
Mechanism of
Indication
Adverse
Special
Frequency and
Action
Reaction
Precaution
Timing
Generic:
Dosage:
Anti-inflammatory, Relief of moderate CNS:Somnolence,
Use cautiously
headache,
insomnia,
mefenamic acid
500mg/capsule
analgesic, and
pain.
with asthma, renal
fatigue, tinnitus,
antipyretic
or hepatic
ophthalmic effect
activities related
impairment, peptic
Dermatologic: Rash
Brand:
Route:
to inhibition of
ulcer disease, GI
pruritus, dry mucus
membranes,
Harafev
PO
prostaglandin
bleeding,
stomatitis
synthesis.
hypertension,
GI:Nausea, vomiting,
heart pregnancy,
dyspepsia, GI pain,
diarrhea, constipation, and lactation.
Frequency:
flatulence, ulcers, GI
bleeding
Q6H
Classification
Contraindication
Side Effects
Functional:
Contraindicated
Dizziness,
Non-steroidal Antiwith
tiredness,
inflammatory Drug
hypersensitivity to sweating
mefenamic acid,
Timing:
aspirin allergy,
6 12 6 12
Chemical:
and as treatment
of preoperative
pain with coronary
bypass grafting.
Clinical Instructor: ______Zanita Glenda A. Plaga, RN______
Reference: Karch, A. (2011). Nursing Drug Guide. Philadelphia:
Wiliams and Wilkins
1
Nursing
Responsibilities
1.Note for any
allergies, renal or
hepatic failure, CV
and GI conditions,
pregnancy, and
lactation.
2.Check for skin
color, lesions,
orientation, reflexes.
3. Recheck name of
drug and expiration
date.
3.Give with milk or
food when GI upset
occurs.
4. Encourage and
ensure patient to
comply with drug
regimen.
5. Discontinue drug
if adverse effects
happen.
Lippincott
COLLEGE OF NURSING
La Paz, Iloilo City
DRUG STUDY
Name of Patient: ____Princess Hermonio ______

Bed/ Ward No.: __________________
Attending Physician:
________________________________________
Age: ________________
_____________________________________
Name of Drug
Dosage, Route,
Mechanism of
Indication
Adverse
Special
Frequency and
Action
Reaction
Precaution
Timing
Generic:
Dosage:
salbutamol
500mg/capsule
Brand:
Route:
PO
Classification
Functional:
Frequency:
Chemical:
Contraindication
Nursing
Responsibilities
Side Effects
Timing:

Wiliams and Wilkins
Reference: Karch, A. (2011). Nursing Drug Guide. Philadelphia: Lippincott

COLLEGE OF NURSING
La Paz, Iloilo City
DRUG STUDY
Name of Patient: ___Pricess Hermonio_______

________________________________________
Age: ________________
_____________________________________
Name of Drug
Dosage,
Mechanism of
Indication
Adverse Reaction
Special
Route,
Action
Precaution
Frequency
and Timing
CNS: lethargy, hallucinations,
Broad spectrum for
Generic:
Dosage:
Bactericidal:
Use
seizures
adults
and
children;
amoxicillin
500mg/capsul Inhibits synthesis
cautiously
GI: diarrhea, abdominal pain,
treatment of tonsillitis
e
of cell wall of
with renal
and pharyngitis caused glossitis, stomatitis,gastritis, sore
mouth and furry tongue,
sensitive
disorders,
by Streptococcus
pseudomembranous
Brand:
organisms,
pregnant
pyogenes, infections
colitis,enterocolitis, bloody
Route:
causing cell death. due to susceptible
women and
diarrhea
strains
of
H.
influenza,
GU:Nephritis
PO
lactating
E. coli, Proteus
Hematologic: Anemia,
women.
thrombocytopenia, leukopenia,
mirabilis, N.
Classification
Functional:
Antibiotics
Chemical:
Frequency:
Q8H
Timing:
6 2 10
gonorrheae, S.
pnuemonae,
Enterococcus faecalis,
streptococci
neutropenia, prolonged bleeding

time.
Others: Superinfections, fever
wheezing vaginitis
Contraindication
Contraindicated
with
hypersensitivity to
penicillin,
cephalosphorins
and other
allergens.
Side Effects
Nausea, vomiting, rash
Nursing
Responsibilities
1.Note for any
allergies to penicillin,
cephalosphorins and
other allergens , renal
or hepatic failure, CV
and GI conditions,
pregnancy, and
lactation.
2.Culture infected
area priortreatment.
3. Ensure compliance
to drug regimen,
ensure around-theclock doding.
4. Provide health
teachings susch as
importance of not selfmedicating.
5. Tell client to report
signs of adverse
reactions and
immediately seek
consultation.

Wiliams and Wilkins
Reference: Karch, A. (2011). Nursing Drug Guide. Philadelphia: Lippincott

COLLEGE OF NURSING
La Paz, Iloilo City
DRUG STUDY
Name of Patient: _____Princess Hermonio _________

________________________________________
Age: ________________
_____________________________________
Name of Drug
Dosage, Route,
Mechanism of
Indication
Adverse
Special
Frequency and
Action
Reaction
Precaution
Timing
Generic:
Dosage:
Antihelmethic
Albendazole is
GI discomfort,
Caution with liver
albendazole
400mg/tablet
agents are
indicated for
headache, nausea, impairments.
indicated for the
treatment of
allergic reactions,
treatmenr of
active lesions
pruritus, raised
Patients being
Brand:
Route:
infections by
caused by prok
liver enzymes,
treated for
Wormhooker
PO
certain susceptible tapeworm and
alopecia and dry
neurocysticercosis
worms and are not cystic disease of
mouth, bone
should receive
interchangeable.
the liver, lung and marrow
appropriate steroid
Antihelmenthics
peritoneum
depression.
and anticonvulsant
Frequency:
interfere with
caused by dog
therapy as
BID
metabolic
tapeworm.
required. Oral or
processes in
intravenous
Classification
Contraindication
Side Effects
particular
worms;
corticosteroids
Functional:
Contraindicated
dizziness
should be
Antihelmenthic
with
Timing:
considered to
hypersensitivity to
66
prevent cerebral
albendazole,
hypertensive
Chemical:
pregnancy,
episodes during
benzimidazole
neonates,
the first week of
derivative agents
lactating mothers,
anticysticeral
and liver
therapy.
impairment
Pre-existing
neurocysticercosis
5
Nursing
Responsibilities
1. Monitor blood
counts and liver
function.
2. Administer within
7 days of start of
normal
menstruation in
women of
childbearing age.
3. Adequate
nonhormonal
contraceptive
measures must be
taken during and for
1 mth after therapy.
4.Perform liver
function tests and
blood counts before
and every 2 wk
during high dose
therapy of hydatid
disease.
may also be
uncovered in
patients treated
with albendazole
for other
conditions.
Patients may
experience
neurological
symptoms (e.g.
seizures, increased
intracranial
pressure and focal
signs) as a result
of an inflammatory
reaction caused by
death of the
parasite within the
brain. Symptoms
may occur soon
after treatment;
appropriate steroid
and anticonvulsant
therapy should be
started
immediately.
Cysticercosis may,
in rare cases,
involve the retina.
Before initiating
therapy for
neurocysticercosis,
the patient should
be examined for
the presence of
6
retinal lesions. If
such lesions are
visualized, the
need for
anticysticeral
therapy should be
weighed against
the possibility of
retinal damage
caused by
albendazoleinduced changes
to the retinal
lesion.
Clinical Instructor: ______Zanita Glenda A. Plaga, RN___ Reference: MIMS Philippines. Retrieved from:
http://mims.com/Philippines/drug/info/albendazole/?
q=albendazole&type=brief&mtype=generic

COLLEGE OF NURSING
La Paz, Iloilo City
DRUG STUDY
Name of Patient: ___________________mother________________

________________________________________
Age: ________________
_____________________________________
Name of Drug
Dosage, Route,
Mechanism of
Indication
Adverse Reaction
Special
Nursing
Frequency and
Action
Precaution
Responsibilities
Timing
1. Counsel clients
Generic:
Dosage:
Combination of
Contracetpion
Menstrual
Sex-steroid
about the
Levonorgestrel +
hormonal
irregularities;
dependent
indication of
ethinylestradiol
contraceptives
headache,
cancer; past
the drug and
Route:
inhibits ovulation
dizziness; breast
ectopic
the drug are
Brand:
PO
by modulating
discomfort;
pregnancy;
not indicated
Mycrogynon
pituitary secretion
gynaecomastia;
malabsorption
for preventing
of
depression;
syndromes;
or curing HIV or
gonadotrophins,
disturbance of
functional ovarian
AIDS.
Frequency:
luteinising
appetite; wt
cysts; active liver
2. Monitor blood
OD
hormone and
changes; fluid
disease, recurrent
glucose
concentrations in
follicle stimulating
retention; oedema; cholestatic
patients with
hormone through
changes in libido;
jaundice, history
diabetes. Closely
a negative
hair loss or
of jaundice in
monitor patients
feedback system.
hirsutism; GI
pregnancy;
on long-term
Timing:
They reduce
disturbances
history of CV or
corticosteroids
sperm
(nausea and
renal impairment;
and diabetic
patients on insulin
penetration if
vomiting);
DM; asthma;
for infection.
ovulation does
genitourinary
epilepsy;
3.
Drug is excreted
occur by altering
changes;
migraine;
in breast milk.
the cervical
haematologic
depression;
4. Levonorgestrel
mucus; cause
disorders;
lactation;
(oral) is not
changes in the
endocrine and
conditions
recommended for
endometrium
metabolic
exacerbated by
routine use as a
contraceptive.
which reduce the
disorders;
fluid retention;
8
risk of nidation
and may change
the tubal
transport of the
ova through the
fallopian tubes.
Absorption:
Absorbed by GI
tract.
Bioavailability:
ethinyl estradiol:
38-48%;
levonorgestrel:
100%.
Distribution:
Distribution:
Ethinyl estradiol:
4.3 L/kg;
Levonorgestrel:
1.8 L/kg. Protein
binding: Ethinyl
estradiol: 95-97%;
Levonorgestrel:
97-99% bind to
sex hormonebinding globulin
and albumin.
Metabolism:
Slowly
metabolised.
Estradiol: hepatic
via oxidation and
conjugation in GI
tract;
hydroxylated via
CYP3A4 to
cholestatic
jaundice; local skin
reactions; chorea;
contact lens
intolerance;
steeping of corneal
curvature;
pulmonary
thromboembolism;
carbohydrate
and/or glucose
intolerance;
depression;
chloasma; BP
increase, liver
impairment;
reduced menstrual
loss, 'spotting' in
early cycles,
absence of
withdrawal
bleeding; rarely
photosensitivity;
increased risk in
breast cancer;
elevation of plasma
bound iodine,
cortisol and thyroid
binding,
erythrocyte
sedimentation may
be accelerated;
increases in
plasma copper,
iron and alkaline
phosphatase; may
9
hypercalcaemia;
CV and gall
bladder diseases;
lipid effects;
familial defects of
lipoprotein
metabolism;
patients at risk of
venous
thromboembolism
, breast cancer,
preexisting
uterine
leiomyomata and
benign hepatic
adenoma; family
history of arterial
disease in 1st
degree relative
<45 yr; BP >
systolic 140
mmHg and
diastolic 90
mmHg; >35 yr;
BMI 30-39 kg/m2;
migraine without
focal aura,
controlled with
5HT1; GI upset
(vomiting and
diarrhoea),
missed pills and
interaction with
other drugs may
require additional
contraceptive
5. Instruct patients to
take
levonorgestrel
emergency
contraceptive as
soon as possible
and not more than
72 h after
unprotected
intercourse or
known or
suspected
contraceptive
failure.
6. Monitor VS of
client.
7. Recheck name
of drug and
expiration date
8. Tell patient to
report to health
care provider
immediately if
adverse effect
occurs.
Classification
Functional:
Cotraceptive
Chemical:
Progesterone;
Emergency
contraceptive
metabolites; firstpass effect;

enterohepatic
recirculation;
reversibly
converted to
estrone and
estriol.
Levonorgestrel:
hepatic involving
CYP3A4;
undergoes
reduction and
conjugation
followed by
hydroxylation;
forms
metabolites.
Excretion: Half life
elimination:
estradiol: 12-23
hr;
levonorgestrel:
22-49 hr.
Excretion:
levonorgestrel:
urine (40-68%
parent drug and
metabolites) and
faeces (16-48%
as metabolites);
estradiol: through
urine as
metabolites
estrone and
estriol, also
affect serum
triglyceride and
lipoprotein levels;
retinal vascular
thrombosis.
Potentially Fatal:
Hepatic tumours;
increased risk of
thromboembolism.
Contraindicatio
n
Pregnancy,
undiagnosed
vaginal bleeding,
severe arterial
disease (or family
history of
atherogenic lipid
profile); liver
adenoma;
porphyria; after
evacuation of
hydatidiform
mole; history of
breast cancer;
hepatic
impairment;
thrombophloebitis
10
Side Effects
Acne,
hypertension,
abdominal pain,
nausea, vomiting
and
diarrhea,vaginitis,
dysmenorrhea,
breast pain,
abnormal pap
smear and
decreased libido,
weight gain and
fatigue, back pain
precautions.
Should be taken
at same time
each day.
through faeces in
small quantities
as glucuronide
and sulphate
conjugates.
or
thromboembolic
disorders; breast
carcinoma except
in selected
patients being
treated for
metastatic
disease;
oestrogendependent
tumour; smoking
40 cigarettes
daily; >50 yr;
diabetes
complications
present; BMI >39
kg/m2; migraine
with typical focal
aura, lasting >72
hr despite
treatment or
migraine treated
with ergot
derivatives; BP
>160 mmHg
systolic and 100
mmHg diastolic;
transient
ischaemic attacks
without
headaches; SLE;
gallstones; history
of haemolytic
uraemic
syndrome, pruritis
11
during pregnancy;
cholestatic
jaundice; chorea
or deterioration of
otosclerosis
pemphigoid;
breast feeding
during 1st 6 mth
after delivery.
Reference: MIMS.COM
12
13
14
15
16
References:
MIMS.com
http://www.drugs.com/pregnancy/levonorgestrel.html
http://medical-dictionary.thefreedictionary.com/levonorgestrel
17

CHN Drug Study

Uploaded by

Copyright:

Available Formats

CHN Drug Study

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

CHN Drug Study

Uploaded by

Copyright:

Available Formats

WEST VISAYAS STATE UNIVERSITY

Name of Patient: _mother hermonio____________

Name of Patient: Princess Hermonio __

Clinical Instructor: Zanita Glenda A. Plaga, RN

Reference: Karch, A. (2011). Nursing Drug Guide. Philadelphia: Lippincott

WEST VISAYAS STATE UNIVERSITY

Name of Patient: _Pricess Hermonio_____

neutropenia, prolonged bleeding

Clinical Instructor: Zanita Glenda A. Plaga, RN

Reference: Karch, A. (2011). Nursing Drug Guide. Philadelphia: Lippincott

WEST VISAYAS STATE UNIVERSITY

Name of Patient: _Princess Hermonio _____

WEST VISAYAS STATE UNIVERSITY

Name of Patient: ___mother

metabolites; firstpass effect;

Clinical Instructor: Zanita Glenda A. Plaga, RN

You might also like